Can the RSV vaccine protect the most vulnerable? new study aims to find out
NCT ID NCT07296120
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether the RSV vaccine Abrysvo can help blood cancer patients who have had a stem cell transplant or CAR-T therapy build immunity against RSV. Researchers will measure antibody levels before and after vaccination in 30 adults. The goal is to see if the vaccine triggers a strong enough immune response to prevent serious respiratory infections.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Respiratory Syncytial Virus Prefusion F Vaccine (RSVpreF, brand name Abrysvo)
- What this could lead to
- If it works, this could show that the RSV vaccine protects vulnerable blood cancer patients from severe respiratory infections after transplant or CAR-T therapy.
- What could go wrong
- This is a small, early-phase study with only 30 participants, so results may not apply to everyone. The vaccine may not produce a strong immune response in these patients due to their weakened immune systems.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BONE MARROW TRANSPLANT - AUTOLOGOUS OR ALLOGENEIC are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Cooper University Hospital
Camden, New Jersey, 08103, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can specially trained immune cells flush out hidden HIV?
- Frailty check may steer safer cancer care for seniors
- Could gratitude exercises aid blood cancer recovery?
- AI platform aims to unlock Real-World cancer data on a massive scale
- Can a new tracer light up cancer growth?
- Could a walk a day keep brain fog away after a stem cell transplant?